Filing Flows › Longevity Health Holdings (XAGE) › Q3 2025
Longevity Health Holdings (XAGE) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 14, 2025
Longevity Health Holdings (XAGE) reported revenue of $426K for the third quarter 2025 (Q3 2025), up 21-fold from a year earlier and -15% from the quarter before. Operating margin was -345.4%, net loss $1.4M (335.7% of revenue).
Longevity Health Holdings, Q3 2025: revenue $426K (21× year over year), operating margin -345.4%, net loss $1.4M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $426K | -15% | 21× |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$1.4M | — | — |
| Operating cash flow | −$1.4M | — | — |
What changed
Revenue was $426K in Q3 2025, up 1975% year over year and down 15% from the previous quarter.
Gross margin was 59.8%, down 16.7 points from a year earlier. Operating costs exceeded revenue by $1.5M, an operating margin of -345.4%. Operating expenses grew 20% against revenue growth of 1975%. The fastest-growing cost line was Sales & marketing (+199%). The quarter ended with a net loss of $1.4M, narrower than the previous quarter's $1.9M loss.
Operating cash flow was −$1.4M. Non-cash charges added back $16K of depreciation and amortization and $190K of share-based compensation. Working capital and other items used $210K.
Questions
What was Longevity Health Holdings' revenue in the third quarter 2025?
Longevity Health Holdings (XAGE) reported revenue of $426K for the third quarter 2025 (Q3 2025), up 21-fold from a year earlier and -15% from the quarter before.
Was Longevity Health Holdings profitable in the third quarter 2025?
Operating loss was $1.5M (-345.4% of revenue) and net loss $1.4M.